Long, L., Yu, Z., Chen, S., Wu, J., Liu, Y., Peng, J., . . . Fu, C. (2021). Pretreatment of Huoxue Jiedu Formula Ameliorates Myocardial Ischaemia/Reperfusion Injury by Decreasing Autophagy via Activation of the PI3K/AKT/mTOR Pathway. Front Pharmacol.
Citação norma ChicagoLong, Linzi, Zikai Yu, ShengJun Chen, Jiarui Wu, Yingying Liu, Jun Peng, Hua Qu, and Changgeng Fu. "Pretreatment of Huoxue Jiedu Formula Ameliorates Myocardial Ischaemia/Reperfusion Injury By Decreasing Autophagy Via Activation of the PI3K/AKT/mTOR Pathway." Front Pharmacol 2021.
Citação norma MLALong, Linzi, et al. "Pretreatment of Huoxue Jiedu Formula Ameliorates Myocardial Ischaemia/Reperfusion Injury By Decreasing Autophagy Via Activation of the PI3K/AKT/mTOR Pathway." Front Pharmacol 2021.